Related Experiment Video
Updated: May 31, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination,
Chad E Groer1, Cullen L Schmid, Alex M Jaeger
1Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA.
Abstract:
Morphine and other opiates mediate their effects through activation of the μ-opioid receptor (MOR), and regulation of the MOR has been shown to critically affect receptor responsiveness. Activation of the MOR results in receptor phosphorylation, β-arrestin recruitment, and internalization. This classical regulatory process can differ, depending on the ligand occupying the receptor. There are two forms of β-arrestin, β-arrestin1 and β-arrestin2 (also known as arrestin2 and arrestin3, respectively); however, most studies have focused on the consequences of recruiting β-arrestin2 specifically. In this study, we examine the different contributions of β-arrestin1- and β-arrestin2-mediated regulation of the MOR by comparing MOR agonists in cells that lack expression of individual or both β-arrestins. Here we show that morphine only recruits β-arrestin2, whereas the MOR-selective enkephalin [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]enkephalin (DAMGO), recruits either β-arrestin. We show that β-arrestins are required for receptor internalization and that only β-arrestin2 can rescue morphine-induced MOR internalization, whereas either β-arrestin can rescue DAMGO-induced MOR internalization. DAMGO activation of the receptor promotes MOR ubiquitination over time. Interestingly, β-arrestin1 proves to be critical for MOR ubiquitination as modification does not occur in the absence of β-arrestin1 nor when morphine occupies the receptor. Moreover, the selective interactions between the MOR and β-arrestin1 facilitate receptor dephosphorylation, which may play a role in the resensitization of the MOR and thereby contribute to overall development of opioid tolerance.
Insights
Morphine and DAMGO differentially engage β-arrestin1 and β-arrestin2 proteins to regulate μ-opioid receptor (MOR) function, impacting internalization and ubiquitination differently.
Area of Science:
- Pharmacology
- Molecular Biology
- Cell Biology
Background:
- Opioid drugs, like morphine, exert effects via the μ-opioid receptor (MOR).
- MOR regulation involves phosphorylation, β-arrestin recruitment, and internalization, processes influenced by specific ligands.
- Two β-arrestin forms exist (β-arrestin1 and β-arrestin2), with β-arrestin2 being the primary focus of previous research.
Purpose of the Study:
- To investigate the distinct roles of β-arrestin1 and β-arrestin2 in regulating MOR activity.
- To compare how different MOR agonists (morphine and DAMGO) interact with β-arrestins.
Main Methods:
- Utilized cells lacking individual or both β-arrestin proteins.
- Compared MOR agonist-induced β-arrestin recruitment, receptor internalization, and ubiquitination.
Main Results:
- Morphine selectively recruits β-arrestin2, while DAMGO recruits both β-arrestin1 and β-arrestin2.
- Both β-arrestins are necessary for MOR internalization, but only β-arrestin2 rescues morphine-induced internalization.
- β-arrestin1 is crucial for DAMGO-induced MOR ubiquitination and dephosphorylation, potentially influencing receptor resensitization.
Conclusions:
- Differential β-arrestin engagement dictates MOR regulatory pathways.
- β-arrestin1 plays a key role in MOR ubiquitination and dephosphorylation, suggesting a role in opioid tolerance development.
Related Concept Videos
Opioid Receptors: Overview
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
GPCR Desensitization
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with one...

